The development of combination therapy involving camptothecins: a review of preclinical and early clinical studies-Reference-Cited by-同舟云学术

The development of combination therapy involving camptothecins: a review of preclinical and early clinical studies

Published:1998-06 Issue:3 Volume:24 Page:205-220
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

de Jonge M.J.A.,Sparreboom A.,Verweij J.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Reference153 articles.

1. Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin;Hsiang;Cancer Res.,1988

2. Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin;Eng;Mol. Pharmacol,1988

3. Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin;Hsiang;Cancer Res,1989

4. Mechanisms of resistance to topoisomerase inhibitors;Chen;Cancer Treat. Res.,1994

5. An early phase II study of CPT-11: a new derivative of camptothecin, for the treatment of leukemia and lymphoma;Ohno;J. Clin. Oncol.,1990

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual 7-ethyl-10-hydroxycamptothecin conjugated phospholipid prodrug assembled liposomes with in vitro anticancer effects;Bioorganic & Medicinal Chemistry;2017-06

2. Solid lipid nanoparticles containing 7-ethyl-10-hydroxycamptothecin (SN38): Preparation, characterization, in vitro, and in vivo evaluations;European Journal of Pharmaceutics and Biopharmaceutics;2016-07

3. Chemistry and Biology of Camptothecin and its Derivatives;Natural Products;2013

4. Nanotech Revolution for the Anti-Cancer Drug Delivery through Blood- Brain-Barrier;Current Cancer Drug Targets;2012-03-01

5. Tumour-Specific Uptake of Anti-Cancer Drugs: The Future is Here;Current Drug Metabolism;2012-01-01